CoverageForm 410-K10-Q8-K13D13G13F

MTEX · Mannatech Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · MTEX

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23
Revenue$24.92M-$29.16M$26.56M-$31.73M$27.74M$29.39M-$32.55M
Cost of Revenue$6.06M-$6.89M$6.83M-$8.11M$6.36M$6.30M-$6.63M
Gross Profit$18.86M-$22.27M$19.74M-$23.62M$21.38M$23.10M-$25.93M
R&D----------
SG&A$9.28M-$9.84M$10.02M-$9.84M$10.86M$10.18M-$6.95M
Total Operating Expenses$19.04M-$20.26M$20.57M-$22.73M$22.52M$22.28M-$25.76M
D&A$261.0K--$293.0K-$400.0K$400.0K$416.0K-$450.0K
Operating Income($180.0K)-$2.01M($833.0K)-$887.0K($1.14M)$820.0K-$172.0K
Interest Expense$104.0K-$109.0K-------
Income Tax$161.0K-$590.0K$206.0K-($389.0K)$496.0K$529.0K-$457.0K
Net Income$950.0K-$1.92M($1.53M)-($328.0K)($624.0K)$1.18M-$18.0K
EPS - Basic$0.49-$1.01($0.80)-($0.17)($0.33)$0.63-$0.01
EPS - Diluted$0.49-$1.01($0.80)-($0.17)($0.33)$0.63-$0.01

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23
Cash & Equivalents$7.01M$6.18M$7.14M$9.32M$11.40M$12.15M$9.20M$7.91M$7.73M$7.93M
Accounts Receivable$10.0K$1.0K$38.0K$102.0K$19.0K$22.0K$99.0K$320.0K$91.0K$149.0K
Inventory$9.67M$10.12M$11.13M$11.82M$10.40M$11.66M$13.15M$13.68M$14.54M$15.33M
Accounts Payable$2.88M$2.41M$4.00M$4.37M$2.07M$3.58M$3.45M$4.88M$4.01M$3.88M
Current Assets$21.20M$20.58M$22.09M$26.55M$26.12M$28.70M$27.93M$28.28M$27.66M$28.58M
Total Assets$29.88M$29.99M$33.92M$36.67M$36.06M$40.57M$39.91M$41.06M$41.21M$42.21M
Current Liabilities$19.47M$18.73M$19.50M$22.58M$20.90M$22.95M$23.96M$26.15M$25.78M$26.31M
Long-term Debt$2.75M$2.75M$2.90M-------
Total Liabilities$35.44M$35.22M$26.97M$29.08M$27.44M$30.57M$31.72M$30.61M$30.72M$31.51M
Stockholders' Equity($5.55M)($5.22M)$6.95M$7.58M$8.61M$10.00M$8.20M$10.45M$10.48M$10.70M
Retained Earnings($13.07M)($14.02M)($2.73M)($341.0K)$1.19M($1.07M)($745.0K)($121.0K)($1.30M)$455.0K

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23
Operating Cash Flow$1.13M--($1.37M)---$1.87M-$1.35M
Investing Cash Flow($129.0K)--($489.0K)---($61.0K)--
Financing Cash Flow($126.0K)--($166.0K)---($250.0K)-($558.0K)
CapEx$129.0K--$489.0K---$61.0K-$104.0K
Free Cash Flow$997.0K--($1.86M)---$1.81M-$1.25M

Ratios

MetricQ1 '26Q4 '25Q3 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23
Profitability
Gross margin75.7%-76.4%74.3%-74.5%77.1%78.6%-79.6%
Operating margin-0.7%-6.9%-3.1%-2.8%-4.1%2.8%-0.5%
EBITDA margin0.3%---2.0%-4.1%-2.7%4.2%-1.9%
Net margin3.8%-6.6%-5.8%--1.0%-2.2%4.0%-0.1%
Free cash flow margin4.0%---7.0%---6.2%-3.8%
FCF / Net income1.05--1.21---1.54-69.28
R&D / Revenue----------
SG&A / Revenue37.3%-33.7%37.7%-31.0%39.1%34.6%-21.3%
Effective tax rate14.5%-23.5%----31.0%-96.2%
Return on assets3.2%-5.7%-4.2%--0.8%-1.6%2.9%-0.0%
Return on equity-17.1%-27.7%-20.2%--3.3%-7.6%11.3%-0.2%
Return on invested capital--15.6%-------
Liquidity
Current ratio1.091.101.131.181.251.251.171.081.071.09
Quick ratio0.590.560.560.650.750.740.620.560.510.50
Cash ratio0.360.330.370.410.550.530.380.300.300.30
Leverage
Debt / Equity-0.50-0.530.42-------
Debt / Assets0.090.090.09-------
Debt / EBITDA33.95---------
Interest coverage-1.7x-18.4x-------
Equity multiplier-5.38-5.744.884.834.194.064.873.933.933.94
Liabilities / Assets1.191.170.800.790.760.750.790.750.750.75
Efficiency
Asset turnover0.83-0.860.72-0.780.690.72-0.77
Inventory turnover0.63-0.620.58-0.700.480.46-0.43
Days sales outstanding0d-0d1d-0d1d4d-2d
Days inventory outstanding583d-590d632d-525d755d793d-845d
Days payable outstanding173d-212d234d-161d198d283d-214d
Cash conversion cycle410d-378d400d-364d558d514d-633d
Valuation
P / E11.8x-9.9x----13.0x-1035.0x
P / B--2.7x2.3x-1.5x1.6x1.5x-1.8x
P / S0.4x-0.6x0.7x-0.5x0.5x0.5x-0.6x
EV / EBITDA85.2x----1.9x-6.1x-18.3x
Growth
Revenue growth (YoY)-6.2%--8.1%-9.6%--2.5%-14.9%---8.3%
Revenue CAGR (3y)---6.4%---7.0%----5.0%
Revenue CAGR (5y)---5.1%-6.2%--5.9%-7.4%-6.6%--
Gross profit growth (YoY)-4.4%--5.7%-14.6%--8.9%-16.5%---7.7%
Operating income growth (YoY)78.4%-126.3%--415.7%-19.8%---87.3%
Net income growth (YoY)------43.5%---98.5%
EPS growth (YoY)------44.1%---98.4%
EPS CAGR (3y)--18.3%-------76.4%
EPS CAGR (5y)--5.9%----17.6%--
FCF growth (YoY)---------220.6%
FCF CAGR (5y)----------
Book value growth (YoY)---30.5%-27.4%-17.8%-6.6%-29.6%--26.0%-42.5%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Product / service

$108.40M total
Product$106.00M · 97.8%
Product And Service Other$1.60M · 1.5%
Associate Fees$400.0K · 0.4%
Associate Service Fees$400.0K · 0.4%

Geographic

$206.90M total
Asia Pacific$66.40M · 32.1%
KR$43.70M · 21.1%
Americas$32.50M · 15.7%
US$22.40M · 10.8%
Asia Pacific Other$11.50M · 5.6%
CN$11.20M · 5.4%
Americas Other$10.10M · 4.9%
EMEA$9.10M · 4.4%

Peer comparison

Same SIC group: Medicinal Chemicals & Botanical Products

CompanyRevenue (last FY)Net marginROE
USNA$925.26M1.2%2.0%
TRUL$1.18B-9.9%-10.2%
CRON$146.59M-6.4%-0.9%
CYAN$24.21M-13.2%-36.1%
MNMD---55.3%

Comparing MANNATECH INC against the 5 most active filers in the same SIC group.

Dividends

$0.00/share trailing 12 months

Ex-datePer share
Jun 14, 2023$0.2000
Mar 15, 2023$0.2000
Dec 13, 2022$0.2000
Sep 13, 2022$0.2000
Jun 14, 2022$0.2000
Mar 15, 2022$0.2000
Dec 14, 2021$1.7000
Sep 14, 2021$0.2000
Jun 1, 2021$0.1600
Mar 15, 2021$0.1600
Dec 15, 2020$1.1600
Sep 14, 2020$0.1600
Jun 11, 2020$0.1250
Mar 12, 2020$0.1250
Dec 12, 2019$0.1250
Sep 9, 2019$0.1250
Jun 20, 2019$0.1250
Mar 21, 2019$0.1250
Dec 6, 2018$0.5000
Sep 14, 2018$0.5000
May 22, 2018$0.1250
Mar 20, 2018$0.1250
Dec 6, 2017$0.1250
Sep 12, 2017$0.1250